| αLA | α-linolenic acid |
| AEs | Adverse events |
| AP/NTS | Area postrema and nucleus tractus solitarius |
| BIA | Bioelectrical impedance analysis |
| BMD | Bone mineral density |
| BMI | Body Mass Index |
| BRAT | Bananas, rice, applesauce, and toast |
| CS | CagriSema |
| DHA | Docosahexaenoic acid |
| DUL | Dulaglutide |
| DEXA | Dual-energy X-ray absorptiometry |
| EPA | Eicosapentaenoic acid |
| FFQ | Food frequency questionnaire |
| FODMAP | Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols |
| HEI | Healthy eating index |
| GERD | Gastroesophageal reflux disease |
| GI | Gastrointestinal |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GLP-1 RAs | Glucagon-like peptide-1 analogs and receptor agonists |
| IBD | Inflammatory bowel disease |
| LCPUFAs | Long-chain polyunsaturated fatty acids |
| LIR | Liraglutide |
| MNT | Medical nutrition therapy |
| PwO | People with obesity |
| RCT | Randomized controlled trials |
| RDN | Registered dietitian/nutritionist |
| SEM | Semaglutide |
| SIBO | Small intestinal bacterial overgrowth |
| T2DM | Type 2 diabetes mellitus |
| TZP | Tirzepatide |
| WHO | World Health Organization |